Riluzole

FDA’s June 2024 list of off-patent, off-exclusivity drugs sees rise in cancer, HIV treatments

This week PharmaCompass brings to you key highlights of the US Food and Drug Administration’s

Does the FDA promote European manufacturers over others? The ice-bucket challenge winner!

This week, Phispers brings you a short analysis on how FDA might be promoting European drugmakers ov

FDA chief named in payments controversy; fake vaccine scandal impacts Indonesian children

This week Phispers brings you scandals such as that of fake vaccines in Indonesia, studies and analy